These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11364247)

  • 1. Protease inhibitors: major study stopped when 3-drug arm proves superior.
    AIDS Treat News; 1997 Mar; (No 266):7-8. PubMed ID: 11364247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
    AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-drug therapy reduces deaths and new AIDS-related illnesses by 50%.
    Baker R
    BETA; 1997 Mar; ():3-4. PubMed ID: 11364527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACTG 320: last of the body count trials?
    PI Perspect; 1997 Mar; (No 21):7. PubMed ID: 11364215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infection.
    Smith D; Berrey MM; Robertson M; Mehrotra D; Markowitz M; Perrin L; Clumeck N; Lazzarin A; Burckhardt B; Weber R; Corey L; Cooper DA
    J Infect Dis; 2000 Sep; 182(3):950-4. PubMed ID: 10950796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACTG 343: (why) we can't relax our grip on viral suppression.
    Maenza JR
    Hopkins HIV Rep; 1998 May; 10(3):10. PubMed ID: 11365491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACTG 320 trial halted as three-drug arm proves superior.
    AIDS Patient Care STDS; 1997 Jun; 11(3):194. PubMed ID: 11361796
    [No Abstract]   [Full Text] [Related]  

  • 8. Stavudine, lamivudine and indinavir in children with advanced HIV-1 infection: preliminary experience.
    Monpoux F; Sirvent N; Cottalorda J; Mariani R; Lefbvre JC
    AIDS; 1997 Oct; 11(12):1523-5. PubMed ID: 9342078
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-HIV agents. Indinavir--3 years and still going strong.
    TreatmentUpdate; 2000 Sep; 12(6):3-4. PubMed ID: 12132460
    [No Abstract]   [Full Text] [Related]  

  • 10. [HIV infection: DuPont Pharma presents the results of its antiretroviral agent].
    Allerg Immunol (Paris); 1998 Apr; 30(4):123-4. PubMed ID: 9631694
    [No Abstract]   [Full Text] [Related]  

  • 11. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
    Hammer SM; Squires KE; Hughes MD; Grimes JM; Demeter LM; Currier JS; Eron JJ; Feinberg JE; Balfour HH; Deyton LR; Chodakewitz JA; Fischl MA
    N Engl J Med; 1997 Sep; 337(11):725-33. PubMed ID: 9287227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study shows three drugs better than two.
    AIDS Alert; 1997 Apr; 12(4):39. PubMed ID: 11364145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV trial stopped early after good results.
    Boulton A
    BMJ; 1997 Mar; 314(7082):699. PubMed ID: 9116542
    [No Abstract]   [Full Text] [Related]  

  • 14. Study confirms that protease inhibitor cocktail can delay HIV disease progression and death.
    Randall P
    NIAID AIDS Agenda; 1997 Mar; ():1-2. PubMed ID: 11364170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major pediatric study stopped early: combination treatment better.
    James JS
    AIDS Treat News; 1997 Jul; (No 274):5-6. PubMed ID: 11364462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACTG 343: three drugs better than two for maintaining HIV suppression.
    Bowersox J
    NIAID AIDS Agenda; 1998 Mar; ():1-2, 10-1. PubMed ID: 11365088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spring cleaning in trial land.
    Gilden D
    GMHC Treat Issues; 1997 Mar; 11(3):4-7. PubMed ID: 11364275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts <200 cells/mm3: 96-week outcomes.
    Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Boonyaprawit P
    Antivir Ther; 2005; 10(8):911-6. PubMed ID: 16430196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug shows potency against HIV.
    Dent Today; 1996 May; 15(5):22, 26. PubMed ID: 9567867
    [No Abstract]   [Full Text] [Related]  

  • 20. Dethroning AZT.
    Gilden D; Falkenberg J; Torres G
    GMHC Treat Issues; 1997 Feb; 11(2):10-3. PubMed ID: 11364106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.